Risks in new drug development: Approval success rates for investigational drugs

被引：298
|
作者：
DiMasi, JA [1 ]
机构：
[1] Tufts Univ, Tufts Ctr Study Drug Dev, Boston, MA 02111 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 05期
关键词：
D O I：
10.1067/mcp.2001.115446
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：297 / 307
页数：11
相关论文
共 50 条
  • [21] The Compassionate Use Advisory Committee (CornpAC) for development of pre-approval access to investigational drugs.
    Mitchell, Edith P.
    Caplan, Arthur
    Bateman-House, Alison
    Ray, Amrit
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Approval success rates of drug candidates based on target, action, modality, application, and their combinations
    Yamaguchi, Shingo
    Kaneko, Masayuki
    Narukawa, Mamoru
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (03): : 1113 - 1122
  • [23] New and investigational antiepileptic drugs
    Striano, Pasquale
    Striano, Salvatore
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (12) : 1875 - 1884
  • [24] APPROVAL OF NEW DRUGS
    WIENER, H
    SCIENCE, 1973, 181 (4095) : 110 - &
  • [25] Clinical Trial Success Rates of Investigational Antileukemic Drugs Presented at the American Society of Hematology (ASH) Meetings
    Miranda, Marisol
    Medeiros, Thalyta
    Lopez, Claudia Guillen
    Mamouni, Kenza
    Cortes, Jorge E.
    BLOOD, 2022, 140 : 10843 - 10844
  • [26] Drug Development and Drug Approval
    Gaynor, Richard
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S139 - S140
  • [27] Understanding drug resistance mechanisms in cholangiocarcinoma: assisting the clinical development of investigational drugs
    Marin, Jose J. G.
    Macias, Rocio I. R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (07) : 675 - 679
  • [28] Dispensing investigational drugs: Regulatory issues and the role of the investigational drug service
    Shehab, N
    Tamer, H
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (18) : 1882 - 1884
  • [29] Drug interactions: Putting success of new drugs at risk
    Lipp, H-P.
    ANNALS OF HEMATOLOGY, 2019, 98 : S69 - S69
  • [30] Tissue-Agnostic Drug Development: A new Path to Drug Approval
    Thein, Kyaw Z.
    Lemery, Steven J.
    Kummar, Shivaani
    CANCER DISCOVERY, 2021, 11 (09) : 2139 - 2144
12345